Danaher (DHR) Net Cash Flow Growth (3y) (2012 - 2026)
Powered by 
Analysis
Danaher (DHR) Net Cash Flow Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 58.74% |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | -44.88% |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | -31.58% |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | -40.43% |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 29.57% |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 0.45% |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 27.19% |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | -35.32% |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | 50.05% |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | 58.68% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 26, 2026 | -44.88% |
| Mar 27, 2026 | -6.77% |
| Dec 31, 2025 | 55.09% |
| Sep 26, 2025 | -46.30% |
| Jun 27, 2025 | 23.71% |
| Mar 28, 2025 | -29.39% |
| Dec 31, 2024 | -137.93% |
| Sep 27, 2024 | 26.27% |
| Jun 28, 2024 | -92.17% |
| Mar 29, 2024 | 44.15% |
| Dec 31, 2023 | -218.14% |
| Sep 29, 2023 | 269.58% |
| Jun 30, 2023 | 5.53% |
| Mar 31, 2023 | 27.85% |
| Dec 31, 2022 | -48.00% |
| Sep 30, 2022 | -47.71% |
| Jul 1, 2022 | -34.11% |
| Apr 1, 2022 | -27.24% |
| Dec 31, 2021 | 7.30% |
| Oct 1, 2021 | -261.23% |